Revisiting the 2015 MDS diagnostic criteria for Parkinson disease: insights from autopsy-confirmed cases

Susan H Fox1, Daniel G Luca2, Ronald B Postuma3,4

  • 1University of Toronto, Movement Disorder Clinic, Edmond J Safra Program in Parkinson Disease, Toronto Western Hospital, Toronto, ON, Canada. Susan.Fox@uhn.ca.

NPJ Parkinson'S Disease
|December 13, 2025
PubMed

Insights

The 2015 International Parkinson and Movement Disorder Society (MDS) diagnostic criteria for Parkinson disease were reviewed. Supportive criteria like levodopa response and rest tremor are useful, but some red flags appear in Parkinson disease.

Area of Science:

  • Neurology
  • Movement Disorders
  • Pathology

Background:

  • The 2015 International Parkinson and Movement Disorder Society (MDS) diagnostic criteria for Parkinson disease (PD) rely on expert consensus.
  • These criteria include core motor features, exclusion criteria, supportive criteria, and red flags.

Purpose of the Study:

  • To evaluate the validity of the 2015 MDS diagnostic criteria for Parkinson disease.
  • To assess the utility of individual criteria in pathologically confirmed cases of Parkinson disease and atypical parkinsonian disorders.

Main Methods:

  • A scoping literature review was conducted from 1988 to 2024.
  • Search terms included "clinicopathological PD" and "atypical parkinsonian disorders", identifying 28 relevant articles.

Main Results:

  • Supportive criteria, particularly excellent levodopa response and rest tremor, were more prevalent in pathologically confirmed Parkinson disease.
  • Absolute exclusion criteria and red flags were more common in atypical parkinsonian disorders.
  • However, supranuclear gaze palsy, rapid gait impairment, and bilateral symptoms were observed in over 5% of Parkinson disease cases.

Conclusions:

  • Empirical data partially supports the 2015 MDS diagnostic criteria for Parkinson disease.
  • Refinement of the criteria may be warranted based on findings in pathologically confirmed cases.
  • Limitations include the scarcity of suitable clinicopathological studies and challenges in applying criteria retrospectively.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
940
Diagnostic and Statistical Manual of Mental Disorders (DSM)01:27

Diagnostic and Statistical Manual of Mental Disorders (DSM)

The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
960